Bronchiectasis: an emerging global epidemic
Abstract Bronchiectasis has an increasing profile within respiratory medicine. This chronic and irreversible airways disease is common but suffers from a lack of evidenced based therapy for patients and, a lack of understanding of its inherent heterogeneity. Research focused on bronchiectasis must t...
Main Authors: | Sanjay H. Chotirmall, James D. Chalmers |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12890-018-0629-1 |
Similar Items
-
Profiling non-tuberculous mycobacteria in an Asian setting : characteristics and clinical outcomes of hospitalized patients in Singapore
by: Chotirmall, Sanjay Haresh, et al.
Published: (2018) -
A case-control study on the risk factors associated with the occurrence of non-tuberculous mycobacteria pulmonary disease in bronchiectasis patients
by: Yinping Feng, et al.
Published: (2023-11-01) -
Chronic infection with non-tuberculous mycobacteria in patients with non-CF bronchiectasis: Comparison with other pathogens
by: Giulia Bonaiti, et al.
Published: (2015-01-01) -
Immunomodulatory effect of macrolides: At what cost?
by: Maria Kipourou, et al.
Published: (2016-01-01) -
Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report
by: C. Addy, et al.
Published: (2018-11-01)